Short‐ and Long‐term Opioid Use in Patients with Oral and Oropharynx Cancer

Abstract

Patients with oral/oropharyngeal cancer are at a very high risk for receiving opioids as part of symptom management during treatment, and a significant portion continues use at 3 and 6 months after treatment completion.